This federal contract award, with ID SPE2DE21D7010|SPE2D625F41FL, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The $14,458.54 contract is a Delivery Order for the Reline Open Implants product line and has a fixed price with economic price adjustment pricing type. The contract has an ultimate completion date of January 3, 2025.
Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division and operates as a for-profit organization. The company has established itself as a key supplier of specialized medical technologies to the U.S. Department of Defense (DoD), Department of Veterans Affairs (VA), and Defense Health Agency (DHA), with a focus on delivering cutting-edge spinal medical devices and surgical solutions. This contract is not associated with any set-aside designation, indicating Nuvasive's strong competitive position in this market.
Generated 4/3/25, 11:14 AM